MA49634A - Arnm modifié codant pour une propionyl-coa-carboxylase et utilisations associées - Google Patents

Arnm modifié codant pour une propionyl-coa-carboxylase et utilisations associées

Info

Publication number
MA49634A
MA49634A MA049634A MA49634A MA49634A MA 49634 A MA49634 A MA 49634A MA 049634 A MA049634 A MA 049634A MA 49634 A MA49634 A MA 49634A MA 49634 A MA49634 A MA 49634A
Authority
MA
Morocco
Prior art keywords
carboxylase
propionyl
coa
modified rna
rna coding
Prior art date
Application number
MA049634A
Other languages
English (en)
Inventor
Judith L Campagnari
Zhiliang Cheng
Susan Sobolov-Jaynes
Romesh R Subramanian
Haren Vasavada
Original Assignee
Modernatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc filed Critical Modernatx Inc
Publication of MA49634A publication Critical patent/MA49634A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y401/00—Carbon-carbon lyases (4.1)
    • C12Y401/01—Carboxy-lyases (4.1.1)
    • C12Y401/01041—Methylmalonyl-CoA decarboxylase (4.1.1.41)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y604/00—Ligases forming carbon-carbon bonds (6.4)
    • C12Y604/01—Ligases forming carbon-carbon bonds (6.4.1)
    • C12Y604/01003—Propionyl-CoA carboxylase (6.4.1.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA049634A 2017-07-21 2018-07-20 Arnm modifié codant pour une propionyl-coa-carboxylase et utilisations associées MA49634A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762535289P 2017-07-21 2017-07-21

Publications (1)

Publication Number Publication Date
MA49634A true MA49634A (fr) 2020-05-27

Family

ID=63165470

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049634A MA49634A (fr) 2017-07-21 2018-07-20 Arnm modifié codant pour une propionyl-coa-carboxylase et utilisations associées

Country Status (4)

Country Link
US (1) US20200165593A1 (fr)
EP (1) EP3655040A1 (fr)
MA (1) MA49634A (fr)
WO (1) WO2019018765A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20220070T1 (hr) 2014-04-23 2022-04-01 Modernatx, Inc. Cjepiva nukleinske kiseline
EP3328394A4 (fr) 2015-07-30 2019-03-13 ModernaTX, Inc. Arn épitope peptidiques concatémériques
EP3364949A4 (fr) 2015-10-22 2019-07-31 ModernaTX, Inc. Vaccins anticancéreux
SG11201901941YA (en) 2016-09-14 2019-04-29 Modernatx Inc High purity rna compositions and methods for preparation thereof
MA46766A (fr) 2016-11-11 2019-09-18 Modernatx Inc Vaccin antigrippal
WO2018170270A1 (fr) 2017-03-15 2018-09-20 Modernatx, Inc. Vaccin contre le virus varicelle-zona
WO2019036682A1 (fr) 2017-08-18 2019-02-21 Modernatx, Inc. Variants d'arn polymérase
JP7424976B2 (ja) 2017-11-22 2024-01-30 モダーナティエックス・インコーポレイテッド プロピオン酸血症の治療用のプロピオニルＣｏＡカルボキシラーゼアルファ及びベータサブユニットをコードするポリヌクレオチド
US11911453B2 (en) 2018-01-29 2024-02-27 Modernatx, Inc. RSV RNA vaccines
CN112996854B (zh) 2018-09-19 2024-08-30 摩登纳特斯有限公司 高纯度peg脂质和其用途
US12151029B2 (en) 2018-09-19 2024-11-26 Modernatx, Inc. PEG lipids and uses thereof
MX2021011031A (es) 2019-03-11 2021-12-10 Modernatx Inc Proceso de transcripción in vitro en lotes alimentados.
WO2022150717A1 (fr) 2021-01-11 2022-07-14 Modernatx, Inc. Vaccins contre le virus de la grippe à arn saisonnière
US20220363937A1 (en) 2021-05-14 2022-11-17 Armstrong World Industries, Inc. Stabilization of antimicrobial coatings
EP4525830A1 (fr) * 2022-05-17 2025-03-26 ModernaTX, Inc. Préparation d'arnm hautement concentré
CN118166004B (zh) * 2024-05-14 2024-12-03 北京剂泰医药科技有限公司 用于编码人PCCA或PCCB蛋白的mRNA及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
PL2578685T3 (pl) 2005-08-23 2020-01-31 The Trustees Of The University Of Pennsylvania Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
JP5405122B2 (ja) 2005-12-21 2014-02-05 ワイス・エルエルシー 低粘度のタンパク質製剤およびその用途
WO2009030254A1 (fr) * 2007-09-04 2009-03-12 Curevac Gmbh Complexes d'arn et de peptides cationiques pour transfection et immunostimulation
SI2506857T1 (en) 2009-12-01 2018-08-31 Translate Bio, Inc. Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
US8853377B2 (en) 2010-11-30 2014-10-07 Shire Human Genetic Therapies, Inc. mRNA for use in treatment of human genetic diseases
WO2012129648A1 (fr) 2011-03-25 2012-10-04 University Of Guelph Activation d'expression de protéines de vecteurs de virus adéno-associés
ES2923757T3 (es) 2011-12-16 2022-09-30 Modernatx Inc Composiciones de ARNm modificado
WO2013151664A1 (fr) 2012-04-02 2013-10-10 modeRNA Therapeutics Polynucléotides modifiés pour la production de protéines
EA201492055A1 (ru) 2012-06-08 2015-11-30 Шир Хьюман Дженетик Терапис, Инк. ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
PT2922554T (pt) 2012-11-26 2022-06-28 Modernatx Inc Arn modificado nas porções terminais
WO2014160243A1 (fr) * 2013-03-14 2014-10-02 The Trustees Of The University Of Pennsylvania Purification et évaluation de la pureté de molécules d'arn synthétisées comprenant des nucléosides modifiés
EP3247328B1 (fr) * 2015-01-21 2026-01-07 Genevant Sciences Gmbh Procédés, compositions et systèmes permettant l'administration d'agents thérapeutiques et diagnostiques dans des cellules
WO2016179138A1 (fr) * 2015-05-03 2016-11-10 The Regents Of The University Of Colorado Compositions de propionyl-coa carboxylase et utilisations de celles-ci
WO2017100551A1 (fr) * 2015-12-09 2017-06-15 Alexion Pharmaceuticals, Inc. Séquences utr hétérologues pour l'amplification de l'expression d'arnm

Also Published As

Publication number Publication date
EP3655040A1 (fr) 2020-05-27
WO2019018765A1 (fr) 2019-01-24
US20200165593A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
EP3635927A4 (fr) Réduction de facteur de crête
EP3352776A4 (fr) Répresseurs htt et leurs utilisations
EP3587675A4 (fr) Excavatrice
EP3733978A4 (fr) Excavatrice
EP3708718A4 (fr) Excavatrice
LT3568808T (lt) Metalinė sudvejintosios sąsajos kortelė
EP3509589A4 (fr) Nouvelles utilisations
EP3334706A4 (fr) Pillararènes et utilisations de ceux-ci
EP3356558A4 (fr) Biomarqueurs pathogènes et utilisations associées
EP3643842A4 (fr) Excavatrice
EP3594416A4 (fr) Pelleteuse
EP3608433A4 (fr) Tuyau en acier soudé par cordon vertical
EP3732821C0 (fr) Fourniture sécurisée de clés
ME03554B (fr) Module de production d'éléments en béton, organe de déplacement, utilisation d'une grille pour fabriquer un module et élément en béton
EP3722618A4 (fr) Excavatrice
EP3347021A4 (fr) Cyano-thiénotriazoloazépines et leurs utilisations
FR3029231B1 (fr) Section en beton
EP3592520C0 (fr) Imprimante 3d béton
EP3725960A4 (fr) Pelleteuse
ZA201706673B (en) Modified bituminous binder emulsion
EP3612761C0 (fr) Élément d'accouplement
EP3856191A4 (fr) Nouvelles utilisations
EP3591125A4 (fr) Excavatrice
FR3042807B1 (fr) Autolestage pour banche de coffrage
EP3268200A4 (fr) Démoulage à faible délaminage